CYP19A1 and breast neoplasm: Aromatase activity stimulated breast cancer cell growth [50], aromatase expression levels increased in breast tumors [51], and was the main source of 17β-estradiol in breast tumors and surrounding tissues in postmenopausal women [52], [53].